Country: Svizzera
Lingwa: Taljan
Sors: Swissmedic (Swiss Agency for Therapeutic Products)
haemagglutininum influenzae A (H5N1), neuraminidasum inactivatum (Virus-Stamm A/Vietnam/1194/2004 NIBRG-14)
Medius AG
J07BB02
haemagglutininum influenzae A (H5N1), neuraminidasum inactivatum (Virus-Stamm A/Vietnam/1194/2004 NIBRG-14)
Sospensione iniettabile in un Flaconcino
haemagglutininum influenzae A (H5N1) et neuraminidasum inactivatum (Virus-Stamm A/Vietnam/1194/2004 NIBRG-14) 7.5 µg, adjuvans MF59C.1: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acidum citricum monohydricum, excipiens: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, calcii chloridum dihydricum, conserv.: thiomersalum 50 µg, aqua ad iniectabile, q.s. ad suspensionem pro 0.5 ml.
B
Vaccini
Pandemico Influenzale Vaccino
zugelassen
2018-04-20